Lantheus to receive supply of LEU-derived Mo-99 from ANSTO

12/20/2009 | AuntMinnie.com (free registration)

The Australian Nuclear Science and Technology Organisation has agreed to provide U.S. firm Lantheus Medical Imaging with molybdenum-99 derived from low-enriched uranium for use in its TechneLite generator line being marketed in U.S. and Canada. Lantheus and ANSTO are working with U.S. and Canadian regulators to obtain the necessary approvals for the distribution of LEU-derived Mo-99 in U.S. and Canadian markets.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC